Your browser doesn't support javascript.
loading
Locally advanced hypopharyngeal squamous cell carcinoma: single-institution outcomes in a cohort of patients curatively treated either with or without larynx preservation.
Reis, Isabel; Aguiar, Artur; Alzamora, Cristiana; Ferreira, Carolina; Castro, Vera; Soares, André; Lobão, Marisa.
Afiliação
  • Reis I; MDs, Radiation Oncologists, Radiation Oncology Department, Instituto Português de Oncologia do Porto Francisco Gentil (IPO-Porto), Porto, Portugal.
  • Aguiar A; MDs, Radiation Oncologists, Radiation Oncology Department, Instituto Português de Oncologia do Porto Francisco Gentil (IPO-Porto), Porto, Portugal.
  • Alzamora C; MDs, Radiation Oncology Residents, Radiation Oncology Department, Instituto Português de Oncologia do Porto Francisco Gentil (IPO-Porto), Porto, Portugal.
  • Ferreira C; MDs, Radiation Oncology Residents, Radiation Oncology Department, Instituto Português de Oncologia do Porto Francisco Gentil (IPO-Porto), Porto, Portugal.
  • Castro V; MDs, Radiation Oncologists, Radiation Oncology Department, Instituto Português de Oncologia do Porto Francisco Gentil (IPO-Porto), Porto, Portugal.
  • Soares A; MDs, Radiation Oncologists, Radiation Oncology Department, Instituto Português de Oncologia do Porto Francisco Gentil (IPO-Porto), Porto, Portugal.
  • Lobão M; MDs, Radiation Oncologists, Radiation Oncology Department, Instituto Português de Oncologia do Porto Francisco Gentil (IPO-Porto), Porto, Portugal.
Radiol Bras ; 49(1): 21-5, 2016.
Article em En | MEDLINE | ID: mdl-26929457
OBJECTIVE: The present study was aimed at describing a single-institution experience in the curative treatment of patients diagnosed with locally advanced hypopharyngeal squamous cell carcinoma. MATERIALS AND METHODS: Data concerning all patients treated for locally advanced hypopharyngeal squamous cell carcinoma between January 2006 and June 2012 were reviewed. RESULTS: A total of 144 patients were included in the present study. The median follow-up period was 36.6 months. Median survival was 26 months, and 2-year and 5-year overall survival rates were, 51% and 30.5%, respectively. Median recurrence-free survival was 18 months and 2-year and 5-year recurrence-free survival rates were 42.8% and 28.5%, respectively. CONCLUSION: The outcomes in the present series are in line with the literature.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Radiol Bras Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Portugal País de publicação: Brasil

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Radiol Bras Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Portugal País de publicação: Brasil